FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108432884> ?p ?o ?g. }

• W3108432884 endingPage "271" @default.
• W3108432884 startingPage "264" @default.
• W3108432884 abstract "Abstract Despite recent advances in treatment, relapses in multiple myeloma (MM) are inevitable. Off-the-shelf immunotherapeutics represent a promising avenue for research, with various classes of agents under development and several demonstrating deep and durable responses in patients who have exhausted all available therapies. Antibody-drug conjugates (ADCs) seek to improve on naked monoclonal antibodies by delivering a cytotoxic payload directly to tumor cells while largely limiting systemic effects. Belantamab mafodotin, a B-cell maturation antigen (BCMA)–targeted ADC, has shown response rates &gt;30% in a phase 2 trial of highly refractory patients and is being investigated in a variety of settings and combinations. Several other ADCs are in earlier stages of development that target cell surface antigens that are internalized, including BCMA, CD38, CD46, CD56, CD74, and CD138. Bispecifics are designed to bring cytotoxic immune effector cells into proximity with tumor cells, and several agents have shown high response rates in early trials. Current targets include BCMA, CD38, GPRC5d, and FCRH5, and all of these seek to engage T cells through CD3. Bispecifics targeting natural killer (NK) cells through CD16 are still in preclinical development. Trispecific antibodies may represent an advance over bispecifics by providing a T-cell costimulatory signal such as CD28, or alternatively, dual MM antigens to increase specificity of NK or T-cell targeting. This is an area of active preclinical research at this time. Lastly, designed ankyrin repeat proteins, which are small antibody-mimetic proteins with high target-binding affinity, have the potential to block multiple pathways at once and provide stimulatory signals to the immune system." @default.
• W3108432884 created "2020-12-07" @default.
• W3108432884 creator A5004484620 @default.
• W3108432884 creator A5030703994 @default.
• W3108432884 creator A5043510950 @default.
• W3108432884 date "2020-12-04" @default.
• W3108432884 modified "2023-10-16" @default.
• W3108432884 title "Bispecifics, trispecifics, and other novel immune treatments in myeloma" @default.
• W3108432884 cites W1832162035 @default.
• W3108432884 cites W1982877913 @default.
• W3108432884 cites W2009626568 @default.
• W3108432884 cites W2034609970 @default.
• W3108432884 cites W2165238581 @default.
• W3108432884 cites W2221239533 @default.
• W3108432884 cites W2395845086 @default.
• W3108432884 cites W2550790024 @default.
• W3108432884 cites W2560676548 @default.
• W3108432884 cites W2765289319 @default.
• W3108432884 cites W2891360972 @default.
• W3108432884 cites W2899237873 @default.
• W3108432884 cites W2901760736 @default.
• W3108432884 cites W2915696691 @default.
• W3108432884 cites W2921533600 @default.
• W3108432884 cites W2923666301 @default.
• W3108432884 cites W2924578117 @default.
• W3108432884 cites W2924802726 @default.
• W3108432884 cites W2979778744 @default.
• W3108432884 cites W2981223183 @default.
• W3108432884 cites W2981230549 @default.
• W3108432884 cites W2984499287 @default.
• W3108432884 cites W2997301227 @default.
• W3108432884 cites W4230744147 @default.
• W3108432884 cites W766579369 @default.
• W3108432884 doi "https://doi.org/10.1182/hematology.2020000110" @default.
• W3108432884 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7727546" @default.
• W3108432884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33275733" @default.
• W3108432884 hasPublicationYear "2020" @default.
• W3108432884 type Work @default.
• W3108432884 sameAs 3108432884 @default.
• W3108432884 citedByCount "38" @default.
• W3108432884 countsByYear W31084328842020 @default.
• W3108432884 countsByYear W31084328842021 @default.
• W3108432884 countsByYear W31084328842022 @default.
• W3108432884 countsByYear W31084328842023 @default.
• W3108432884 crossrefType "journal-article" @default.
• W3108432884 hasAuthorship W3108432884A5004484620 @default.
• W3108432884 hasAuthorship W3108432884A5030703994 @default.
• W3108432884 hasAuthorship W3108432884A5043510950 @default.
• W3108432884 hasBestOaLocation W31084328841 @default.
• W3108432884 hasConcept C10205521 @default.
• W3108432884 hasConcept C147483822 @default.
• W3108432884 hasConcept C154317977 @default.
• W3108432884 hasConcept C159654299 @default.
• W3108432884 hasConcept C159912055 @default.
• W3108432884 hasConcept C202751555 @default.
• W3108432884 hasConcept C203014093 @default.
• W3108432884 hasConcept C28328180 @default.
• W3108432884 hasConcept C502942594 @default.
• W3108432884 hasConcept C542903549 @default.
• W3108432884 hasConcept C55493867 @default.
• W3108432884 hasConcept C71924100 @default.
• W3108432884 hasConcept C86803240 @default.
• W3108432884 hasConcept C8891405 @default.
• W3108432884 hasConcept C95444343 @default.
• W3108432884 hasConceptScore W3108432884C10205521 @default.
• W3108432884 hasConceptScore W3108432884C147483822 @default.
• W3108432884 hasConceptScore W3108432884C154317977 @default.
• W3108432884 hasConceptScore W3108432884C159654299 @default.
• W3108432884 hasConceptScore W3108432884C159912055 @default.
• W3108432884 hasConceptScore W3108432884C202751555 @default.
• W3108432884 hasConceptScore W3108432884C203014093 @default.
• W3108432884 hasConceptScore W3108432884C28328180 @default.
• W3108432884 hasConceptScore W3108432884C502942594 @default.
• W3108432884 hasConceptScore W3108432884C542903549 @default.
• W3108432884 hasConceptScore W3108432884C55493867 @default.
• W3108432884 hasConceptScore W3108432884C71924100 @default.
• W3108432884 hasConceptScore W3108432884C86803240 @default.
• W3108432884 hasConceptScore W3108432884C8891405 @default.
• W3108432884 hasConceptScore W3108432884C95444343 @default.
• W3108432884 hasIssue "1" @default.
• W3108432884 hasLocation W31084328841 @default.
• W3108432884 hasLocation W31084328842 @default.
• W3108432884 hasOpenAccess W3108432884 @default.
• W3108432884 hasPrimaryLocation W31084328841 @default.
• W3108432884 hasRelatedWork W1530343147 @default.
• W3108432884 hasRelatedWork W1602847563 @default.
• W3108432884 hasRelatedWork W1943797027 @default.
• W3108432884 hasRelatedWork W1971852928 @default.
• W3108432884 hasRelatedWork W1991697133 @default.
• W3108432884 hasRelatedWork W1997716688 @default.
• W3108432884 hasRelatedWork W2038126255 @default.
• W3108432884 hasRelatedWork W2064089409 @default.
• W3108432884 hasRelatedWork W2220102944 @default.
• W3108432884 hasRelatedWork W339756260 @default.
• W3108432884 hasVolume "2020" @default.
• W3108432884 isParatext "false" @default.
• W3108432884 isRetracted "false" @default.
• W3108432884 magId "3108432884" @default.

• next